Encephalitis in an immunocompetent man

Journal of Clinical Virology

Volumn 59, Issue 1, 2014, Pages 1-3

  Barker, Kevin R ^a   Sarafino Wani, Robert ^a   Khanom, Aysha ^a   Griffiths, Paul D ^a   Jacobs, Michael G ^a   Webster, Daniel P ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM;

ACUTE CONFUSION; ADULT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMMUNOCOMPETENCE; MALAISE; MALE; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEIZURE; SOMNOLENCE; TONIC CLONIC SEIZURE; URINE INCONTINENCE; VIRUS ENCEPHALITIS;

BRAIN; CEREBROSPINAL FLUID; DNA, VIRAL; ENCEPHALITIS, HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84891830343     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.05.014     Document Type: Note

References (22)

1. Dennett C., Cleator G.M., Klapper P.E. HSV-1 and HSV-2 in herpes simplex encephalitis: a study of sixty-four cases in the United Kingdom. J Med Virol 1997, 53:1-3.
2. Bergström T., Vahlne A., Alestig K., Jeansson S., Forsgren M., Lycke E. Primary and recurrent herpes simplex virus type 2-induced meningitis. J Infect Dis 1990, 162:322-330.
3. Thomas H.C., Kapadia R.D., Wells G.I., Gresham A.M., Sutton D., Solleveld H.A., et al. Differences in pathogenicity of herpes simplex virus serotypes 1 and 2 may be observed by histopathology and high-resolution magnetic resonance imaging in a murine encephalitis model. J Neurol Surg 2001, 7:105-116.
4. Brown Z. Preventing herpes simplex virus transmission to the neonate. Herpes 2004, 11:175A-186A.
5. Whitley R.J., Lakeman F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin Infect Dis 1995, 20:414-420.
6. Richards J.T., Kern E.R., Overall J.C., Glasgoq L.A. Differences in neurovirulence among isolates of Herpes Simplex Virus types 1 and 2 in mice using four routes of infection. J Infect Dis 1981, 144:464-471.
7. Cook M.L., Stevens J.G. Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Immunity 1973, 7:272-288.
8. Omland L.H., Vestergaard B.F., Wandall J.H. Herpes simplex virus type 2 infections of the central nervous system: a retrospective study of 49 patients. Scand J Infect Dis 2008, 40:59-62.
9. Corey L., Whitley R.J., Stone E.F. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet 1988, 1:1-4.
10. Whitley R.J., Soong S.J., Dolin R., Galasso G.J., Ch'ien L.T., Alford C.A. Adenine arabinoside therapy of biopy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med 1977, 297:289-294.
11. Johnson R.T. Acute encephalitis. Clin Infect Dis 1996, 23:219-226.
12. Health Protection Agency Prospective aetiological study of encephalitis 2007, vol. 1:1-14.
13. Granerod J., Ambrose H.E., Davies N.W., Clewley J.P., Walsh A.L., Morgan D., et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010, 10:835-844.
14. Mailles A., Stahl J.P. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 2009, 49:1838-1847. Steering Committee and Investigators Group.
15. Solomon T., Michael B.D., Smith P.E., Sanderson F., Davies N.W., Hart I.J., et al. Management of suspected viral encephalitis in adults - Association of British Neurologists and British Infection Association National Guidelines. J Infect 2012, 64:347-373.
16. Whitley R.J. Herpes simplex encephalitis: adolescents and adults. Antiviral Res 2006, 71:141-148.
17. Stahl J.P., Mailles A., De Broucker T. Herpes simplex encephalitis and management of aciclovir in encephalitis patients in France. Epidemiol Infect 2012, 140:372-381. Steering Committee and Investigators Group.
18. Schulte E.C., Sauerbrei A., Hoffmann D., Zimmer C., Hemmer B., Mühlau M. Aciclovir resistance in herpes simplex encephalitis. Ann Neurol 2010, 67:830-833.
19. Aurelius E., Franzen-Röhl E., Gilmåker M., Akre O., Grillner L., Jorup-Rönstroöm C., et al. Long-term valaciclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial. Clin Infect Dis 2012, 54:1304-1313.
20. Kimberlin D.W., Whitley R.J., Wan W., Powell D.A., Storch G., Ahmed A., et al. Oral aciclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med 2011, 365:1284-1292.
21. Langenberg A.G.M., Corey L., Ashley R., Leong W.P., Straus S.E. A prospective study of new infections with herpes simplex virus type 1 and 2. N Eng J Med 1999, 341:1432-1438.
22. Whitley R.J., Alford C.A., Hirsch M.S., Schooley R.T., Luby J.P., Aoki F.Y., et al. Vidarabine verses aciclovir therapy in herpes simplex encephalitis. N Engl J Med 1986, 314:144-149.